Bitter orange () fruit contains several adrenergic agonists, primarily p-synephrine, but also octopamine and tyramine, as well as numerous flavonoids. Bitter orange has no specific lactation-related uses, but high dosages are often used in weight-loss agents. No data exist on the excretion of any components of bitter orange into breastmilk or on the safety and efficacy of bitter orange in nursing mothers or infants. Bitter orange is "generally recognized as safe" (GRAS) as a food and flavoring by the U.S. Food and Drug Administration. High dosages of bitter orange are often combined with caffeine and other stimulants in weight loss products, and the combinations may cause cardiac stimulation. Because of the lack of information on high dosages used in supplements and because animal data indicate that the adrenergic agents in bitter orange might decrease milk production, it should probably be avoided by nursing mothers, especially while nursing a newborn or preterm infant. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information about dietary supplements is available elsewhere on the LactMed Web site.
酸橙果实含有多种肾上腺素能激动剂,主要是对-辛弗林,但也有章鱼胺和酪胺,以及多种黄酮类化合物。酸橙没有与哺乳期相关的特定用途,但高剂量常用于减肥产品中。目前尚无关于酸橙任何成分在母乳中的排泄情况的数据,也没有关于酸橙在哺乳期母亲或婴儿中的安全性和有效性的数据。美国食品药品监督管理局将酸橙作为食品和调味剂“一般认为是安全的”(GRAS)。高剂量的酸橙通常与咖啡因和其他兴奋剂一起用于减肥产品中,这些组合可能会引起心脏刺激。由于缺乏关于补充剂中高剂量使用情况的信息,并且动物数据表明酸橙中的肾上腺素能药物可能会减少乳汁分泌,哺乳期母亲可能应避免食用酸橙,尤其是在哺乳新生儿或早产儿期间。膳食补充剂不需要获得美国食品药品监督管理局广泛的上市前批准。制造商有责任确保安全性,但在膳食补充剂上市前不需要证明其安全性和有效性。膳食补充剂可能含有多种成分,标签上的成分与其实际成分或含量之间往往存在差异。制造商可能会与独立组织签约以核实产品或其成分的质量,但这并不能证明产品的安全性或有效性。由于上述问题,一种产品的临床试验结果可能不适用于其他产品。有关膳食补充剂的更详细信息可在LactMed网站的其他地方获取。